Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00547625 · ClinicalTrials.gov registry record · Phase 2
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems
A Phase 2 study of Prostatic Hyperplasia and Prostate, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 275
- Enrollment target
- 1
- Study location
NCT00547625 is a Phase 2 study of Prostatic Hyperplasia and Prostate that has completed, run by Eli Lilly and Company. The registered enrollment target is 275 participants, below the 3,006-participant average among 5 other Prostatic Hyperplasia trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00547625, a Phase 2 study of Prostatic Hyperplasia and Prostate, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 275 participants
- Enrollment target
- 1
- Study location
Study Summary
Study to look at safety and effectiveness of different doses of tadalafil on prostate related genital/urinary tract problems.
Conditions Studied
Interventions
- DRUG placebo
- DRUG tadalafil
Study Locations (1)
Illinois
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00547625
The ClinicalTrials.gov registry entry for NCT00547625 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,006-participant average among 5 other Prostatic Hyperplasia trials with a reported enrollment target (91% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Prostatic Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00547625 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00547625 about?
NCT00547625 is a clinical study titled "Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems". Study to look at safety and effectiveness of different doses of tadalafil on prostate related genital/urinary tract problems.
What is the current status of trial NCT00547625?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 275 participants. The study started on 2004-10. Estimated completion is 2005-07.
What conditions does trial NCT00547625 study?
This clinical trial studies the following conditions: Prostatic Hyperplasia, Prostate.
What interventions are being tested in trial NCT00547625?
The interventions under investigation include: placebo (DRUG), tadalafil (DRUG).
Who is sponsoring clinical trial NCT00547625?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00547625 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
RECRUITING · Phase 2
-
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
RECRUITING
-
Pelvic Floor Physical Therapy to Reduce Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
ACTIVE NOT RECRUITING · NA
-
Prostate Mechanical Imager (PMI) Clinical Bridging Study
COMPLETED
-
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.